Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Prostatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 2Stomatitis 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Melanoma 1Malignant Ascites 1Lung Cancer Metastatic 1Colonic Neoplasms 1

Interventions

Low-Level Light Therapy 14Fibroblast Growth Factor 7 10Cisplatin 6Standard of Care 5avasopasem manganese 4Radiotherapy, Intensity-Modulated 4Propolis 4Mouthwashes 4Cryotherapy 4Water 3Sodium Bicarbonate 3Saline Solution 3Radiotherapy 3Laser Therapy 3Injections 3Drug Therapy 3Control Groups 3Benzydamine 3golotimod 2aluminum hydroxide, magnesium hydroxide, drug combination 2Xylitol 2Vitamin E 2Vitamin B 12 2Sodium Chloride 2Saliva, Artificial 2RRx-001 2Practice Guidelines as Topic 2Lidocaine 2Honey 2Glutamine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomatitis × regramostim × Clear all
NCT01806272 2013-03-29

Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis

Sun Yat-sen University

Phase 2 Unknown
160 enrolled
Head & Neck

Nasopharyngeal Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡